Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment
Background: Gestational diabetes is a pathological condition that manifests between the 2nd and 3rd trimesters of pregnancy. It is distinguished by substantial insulin resistance induced by the secretion of placental hormone. Adipocytes secrete a particular type of adipocytokine called zinc a2 glyc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy / Mustansiriyah University
2025-01-01
|
| Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587657328197632 |
|---|---|
| author | Bara Nahdh Saleem Manal Khalid Abdulridha Hind Abdalkhaliq Showman Manal Sabbar |
| author_facet | Bara Nahdh Saleem Manal Khalid Abdulridha Hind Abdalkhaliq Showman Manal Sabbar |
| author_sort | Bara Nahdh Saleem |
| collection | DOAJ |
| description |
Background: Gestational diabetes is a pathological condition that manifests between the 2nd and 3rd trimesters of pregnancy. It is distinguished by substantial insulin resistance induced by the secretion of placental hormone. Adipocytes secrete a particular type of adipocytokine called zinc a2 glycoprotein (ZAG), and numerous reasearches have suggested that ZAG is involved in crucial physiological processes such as glucose metabolism.
Objectives: This study was designed to evaluate the ZAG level in GDM pregnant women on different therapeutic modalities and whether it could be used as a biomarker in the diagnosis of GDM. Also to study the correlation between ZAG with glycemic status. Method: The research included 76 pregnant women (age 18–40), 22 healthy pregnant women (group1), 30 newly diagnosed GDM pregnant women (group2), and 24 GDM on different therapeutic modalities (group3), in the 2nd or 3rd trimester; all the demographic and glycemic characteristics were measured.
Result: There was no substantial difference in ZAG levels of the study groups from one another (P≥ 0.05); therefore, pregnant women with GDM in group 2 exhibited the greatest level of ZAG. Significant variation in ZAG levels was observed among subgroups of treated GDM pregnant women (p<0.01). The metformin group exhibited the lowest level of ZAG. There was significant increase in Fasting Blood Glucose and Glycated Hemoglobin in GDM pregnant women group 2 and 3 compared to group 1 pregnant women, meanwhile, slight increase in fasting plasma insulin level and Homeostatic Model Assessment of Insulin Resistance (HOMA IR) among group 2 and 3 compared to group 1 pregnant women, though not noticeable (P≥ 0.05). No statistically significant association was reported with ZAG and glycemic indices.
Conclusion: there was no statistically significant variation in ZAG level within study groups (P≥ 0.05), hence, GDM pregnant women in group 2 showed the highest level. ZAG could not be used as an indicator in the diagnosis of GDM.
|
| format | Article |
| id | doaj-art-92e4c8fc99d54f7bad3243a47d5c3d89 |
| institution | Kabale University |
| issn | 1815-0993 2959-183X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | College of Pharmacy / Mustansiriyah University |
| record_format | Article |
| series | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| spelling | doaj-art-92e4c8fc99d54f7bad3243a47d5c3d892025-01-24T13:47:26ZengCollege of Pharmacy / Mustansiriyah UniversityAl-Mustansiriyah Journal of Pharmaceutical Sciences1815-09932959-183X2025-01-0125110.32947/ajps.v25i1.1127Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without TreatmentBara Nahdh Saleem0Manal Khalid Abdulridha1Hind Abdalkhaliq Showman2Manal Sabbar3Department of Clinical Pharmacy / College of Pharmacy / Mustansiriyah University. IraqDepartment of Clinical Pharmacy / College of Pharmacy / Mustansiriyah University. IraqDepartment of Obstetrics and Gynecology / College of Medicine / Mustansiriyah University. IraqDepartment of Obstetrics and Gynecology/ Gragash Hospital/ Dubai Background: Gestational diabetes is a pathological condition that manifests between the 2nd and 3rd trimesters of pregnancy. It is distinguished by substantial insulin resistance induced by the secretion of placental hormone. Adipocytes secrete a particular type of adipocytokine called zinc a2 glycoprotein (ZAG), and numerous reasearches have suggested that ZAG is involved in crucial physiological processes such as glucose metabolism. Objectives: This study was designed to evaluate the ZAG level in GDM pregnant women on different therapeutic modalities and whether it could be used as a biomarker in the diagnosis of GDM. Also to study the correlation between ZAG with glycemic status. Method: The research included 76 pregnant women (age 18–40), 22 healthy pregnant women (group1), 30 newly diagnosed GDM pregnant women (group2), and 24 GDM on different therapeutic modalities (group3), in the 2nd or 3rd trimester; all the demographic and glycemic characteristics were measured. Result: There was no substantial difference in ZAG levels of the study groups from one another (P≥ 0.05); therefore, pregnant women with GDM in group 2 exhibited the greatest level of ZAG. Significant variation in ZAG levels was observed among subgroups of treated GDM pregnant women (p<0.01). The metformin group exhibited the lowest level of ZAG. There was significant increase in Fasting Blood Glucose and Glycated Hemoglobin in GDM pregnant women group 2 and 3 compared to group 1 pregnant women, meanwhile, slight increase in fasting plasma insulin level and Homeostatic Model Assessment of Insulin Resistance (HOMA IR) among group 2 and 3 compared to group 1 pregnant women, though not noticeable (P≥ 0.05). No statistically significant association was reported with ZAG and glycemic indices. Conclusion: there was no statistically significant variation in ZAG level within study groups (P≥ 0.05), hence, GDM pregnant women in group 2 showed the highest level. ZAG could not be used as an indicator in the diagnosis of GDM. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1127Gestational diabetes GDMZinc alpha 2-glycoprotein ZAGGlucose MetabolismCorrelation |
| spellingShingle | Bara Nahdh Saleem Manal Khalid Abdulridha Hind Abdalkhaliq Showman Manal Sabbar Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment Al-Mustansiriyah Journal of Pharmaceutical Sciences Gestational diabetes GDM Zinc alpha 2-glycoprotein ZAG Glucose Metabolism Correlation |
| title | Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment |
| title_full | Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment |
| title_fullStr | Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment |
| title_full_unstemmed | Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment |
| title_short | Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment |
| title_sort | assessment of zinc alpha 2 glycoprotein level in gestational diabetes woman in respect to glycemic status with and without treatment |
| topic | Gestational diabetes GDM Zinc alpha 2-glycoprotein ZAG Glucose Metabolism Correlation |
| url | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1127 |
| work_keys_str_mv | AT baranahdhsaleem assessmentofzincalpha2glycoproteinlevelingestationaldiabeteswomaninrespecttoglycemicstatuswithandwithouttreatment AT manalkhalidabdulridha assessmentofzincalpha2glycoproteinlevelingestationaldiabeteswomaninrespecttoglycemicstatuswithandwithouttreatment AT hindabdalkhaliqshowman assessmentofzincalpha2glycoproteinlevelingestationaldiabeteswomaninrespecttoglycemicstatuswithandwithouttreatment AT manalsabbar assessmentofzincalpha2glycoproteinlevelingestationaldiabeteswomaninrespecttoglycemicstatuswithandwithouttreatment |